What are ResMed's profit margins?

ResMed (RMD) runs a 61.6% gross margin and a 34.2% operating margin, with a 27.4% net margin.

Where do ResMed's ratios come from?

Every ratio is computed from ResMed's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

ResMed RMD Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q3 '26	TTM Q2 '26	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25
Profitability
Gross margin	241.9%+2.8pp	239.1%+2.5pp	236.6%+2.4pp	234.2%+2.7pp	231.5%+3.0pp
Operating margin	133.8%+2.1pp	131.7%+2.0pp	129.7%+3.7pp	126%+4.6pp	121.4%+5.6pp
Net margin	109.5%+1.3pp	108.2%+2.2pp	106.1%+4.2pp	101.9%+5.4pp	96.4%+5.2pp
EBITDA margin	149.3%+2.5pp	146.8%+2.2pp	144.6%+3.8pp	140.7%+4.7pp	136.1%+5.3pp
Free cash flow margin	130.8%+0.4pp	130.4%+4.9pp	125.4%+5.5pp	119.9%+4.5pp	115.4%+7.5pp
Returns
Return on equity	102.2%-0.6pp	102.8%0.0pp	102.7%+1.8pp	100.9%+3.2pp	97.7%+3.4pp
Return on assets	74.7%+0.3pp	74.4%+1.2pp	73.2%+2.6pp	70.6%+3.6pp	67%+4.1pp
Return on invested capital	102.6%+2.2pp	100.4%+3.1pp	97.3%+4.6pp	92.7%+5.9pp	86.8%+6.5pp
Efficiency
Asset turnover	2.7×0.0×	2.7×0.0×	2.8×0.0×	2.8×0.0×	2.8×0.0×
Inventory turnover	9.4×-0.1×	9.4×+0.1×	9.3×+0.1×	9.3×+0.2×	9.1×+0.2×
Liquidity
Current ratio	12.4×-0.4×	12.8×-0.3×	13.1×0.0×	13.1×+0.9×	12.3×+0.4×
Quick ratio	9.3×-0.2×	9.5×0.0×	9.5×+0.2×	9.2×+0.8×	8.4×+0.5×
Cash ratio	4.7×+0.2×	4.4×+0.5×	3.9×+0.6×	3.3×+0.9×	2.3×+0.7×
Leverage
Debt-to-equity	0.7×0.0×	0.7×0.0×	0.6×0.0×	0.6×0.0×	0.7×-0.1×
Debt-to-assets	0.5×0.0×	0.5×0.0×	0.5×0.0×	0.5×0.0×	0.5×-0.1×
Net debt / EBITDA	-0.7×-0.2×	-0.5×-0.3×	-0.2×-0.4×	0.2×-0.6×	0.8×-0.7×
Interest coverage	661.9×—	——	——	——	——
Per Share
Book value per share	$169.91+4.2%	$163.03+4.9%	$155.46+4.3%	$148.99+5.3%	$141.45+4.6%
Valuation
Market capitalization	$145.46B-0.1%	$145.64B+1.1%	$144.05B+3.0%	$139.84B+7.2%	$130.44B+3.0%
Enterprise value	$143.97B-0.4%	$144.62B+0.7%	$143.67B+2.5%	$140.17B+6.4%	$131.77B+2.1%
Price / earnings	99.8×-3.5×	103.4×-3.2×	106.6×-4.4×	110.9×-0.8×	111.7×-5.3×
Price / sales	27.3×-0.6×	28×-0.3×	28.3×+0.2×	28.1×+1.3×	26.8×+0.2×
Price / book	23.4×-0.9×	24.3×-0.8×	25.2×-0.4×	25.5×+0.5×	25×-0.4×
EV / EBITDA	72.6×-3.1×	75.7×-2.3×	78×-2.3×	80.3×+0.5×	79.8×-3.2×
EV / sales	27.1×-0.7×	27.8×-0.4×	28.2×0.0×	28.2×+1.1×	27.1×0.0×
Free cash flow yield	19.3%+0.6pp	18.7%+1.0pp	17.8%+0.6pp	17.1%-0.2pp	17.3%+1.0pp
Earnings yield	16.2%+0.7pp	15.5%+0.5pp	15%+0.5pp	14.6%+0.1pp	14.4%+0.7pp
Dividend yield	3.6%+0.1pp	3.5%+0.1pp	3.4%0.0pp	3.4%-0.2pp	3.6%0.0pp
PEG ratio	4.3×+0.7×	3.6×+0.6×	3×-0.5×	3.5×-1.3×	4.8×-2.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about ResMed.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are ResMed's profit margins?: ResMed (RMD) runs a 61.6% gross margin and a 34.2% operating margin, with a 27.4% net margin.
Where do ResMed's ratios come from?: Every ratio is computed from ResMed's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.